Abstract
This chapter firstly provides an overview of multimorbidity as a complicated clinico-epidemiological, yet reductionist construct of multiple discreet disease(s) occurring in one individual. Current multimorbidity studies highlight taxonomic challenges about the actual nature of disease or chronic disease singly or in clusters and their underlying processes, and clinical practices. Multimorbidity is then viewed through the lens of systems medicine in the future, as multi-layered complex adaptive systems health care. Systems medicine is an interdisciplinary field of science which studies the nature and processes of complex systems of the biological sciences, as well as in information technology applied to medicine. Networks and psychoneuroimmunology and social phenomena form another “branch” of systems medicine. Nevertheless, clinico-epidemiological multi-morbidity, systems medicine and psychoneuroimmunology are very far apart in the literature with few intersecting research publications, despite commonality in the use of biomarkers and biometrics. As multimorbidity care will inevitably embrace new knowledge and technologies, it is important to improve personal- and population-centred care, rather than biomarker and biometrics reductionism. Opportunities must be embraced to transcend fragmented silos of knowledge and reductionistic care into integrated systems from biomarkers to clinical and population networks that help improve individual care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Relative to co-morbidity and multimorbidity indicators, three measurement issues were cited: (1) Limitations in functional status. The degree of independence or difficulty in basic and instrumental activities of daily living should be considered for inclusion in all co-morbidity evaluations. (2) Severity levels of co-morbidity and multimorbidity should address additive and multiplicative relationships. (3) Although biologic and physical responses within individuals are major foci of treatment and care, they are not disconnected from social and psychological events and changes occurring in older patients’ lives.
References
International Research Community on Multimorbidity. The definition of multimorbidity: looking for a consensus. http://crmcspl-blog.recherche.usherbrooke.ca/2014. Cited Accessed 3 Oct 2014.
Feinstein A. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–68.
Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–63.
Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67(3):254–66.
France E, Wyke S, Gunn J, Mair F, McLean G, Mercer S. Multimorbidity in primary care: a systematic review of prospective cohort studies. Br J Gen Pract. 2012;62(597):e297–307.
Britt H, Harrison C, Miller G, Knox S. Prevalence and patterns of multimorbidity in Australia. Med J Aust. 2008;189:72–77.
McDaid O, Hanly MJ, Richardson K, Kee F, Kenny RA, Savva GM. The effect of multiple chronic conditions on self-rated health, disability and quality of life among the older populations of Northern Ireland and the Republic of Ireland: a comparison of two nationally representative cross-sectional surveys. BMJ Open. 2013;3(6):e002571.
Harrison C, Britt H, Miller G, Henderson J. Examining different measures of multimorbidity, using a large prospective cross-sectional study in Australian general practice. BMJ Open. 2014;4(7):e004694.
Violán C, Foguet-Boreu Q, Roso-Llorach A, Rodriguez-Blanco T, Pons-Vigués M, Pujol-Ribera E, Muñoz-Pérez M and Valderas J. Burden of multimorbidity, socioeconomic status and use of health services across stages of life in urban areas: a cross-sectional study. BMC Public Health. 2014;14:530.
Marengoni A, von Strauss E, Rizzuto D, Winblad B, Fratiglioni L. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med. 2009;265(2):288–95.
Lappenschaar M, Hommersom A, Lucas PJ. Probabilistic causal models of multimorbidity concepts. AMIA Annu Symp Proc. 2012;2012:475–84.
Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. Br Med J. 2012;345:e5205.
Barnett K, Mercer S, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multi-morbidity and implications for health care, research and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.
Mercer S. Multimorbidity and the inverse care law in primary care. Br Med J. 2012;344:e4152.
Galenkamp H, Braam AW, Huisman M, Deeg DJ. Somatic multimorbidity and self-rated health in the older population. J Gerontol B Psychol Sci Soc Sci. 2011;66(3):380–86.
Nobrega TC, Jaluul O, Machado AN, Paschoal SM, Jacob Filho W. Quality of life and multimorbidity of elderly outpatients. Clinics (Sao Paulo). 2009;64(1):45–50.
Martin CM, Peterson C. The social construction of chronicity–a key to understanding chronic care transformations. J Eval Clin Pract. 2009;15(3):578–85.
Bayliss EA, Ellis JL, Steiner JF. Seniors’ self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measures. J Clin Epidemiol. 2009;62(5):550–7.
Martin CM. The care of chronic illness in general practice. Ph.D. Thesis. Canberra: Australian National University; 1998.
Kline TJ, Willness C, Ghali WA. Predicting patient complaints in hospital settings. Qual Saf Health Care. 2008;17(5):346–50.
Voorham J, Denig P. Groningen initiative to analyse type 2 diabetes treatment. Computerized extraction of information on the quality of diabetes care from free text in electronic patient records of general practitioners. J Am Med Inform Assoc. 2007;14(3):349–54.
Kontopantelis E, Springate DA, Ashworth M, Webb RT, Buchan IE, Doran T. Investigating the relationship between quality of primary care and premature mortality in England: a spatial whole-population study. Br Med J. 2015;350:h904.
McLean G, Sutton M, Guthrie B. Deprivation and quality of primary care services: evidence for persistence of the inverse care law from the UK Quality and Outcomes Framework. J Epidemiol Community Health. 2006;60(11):917–22.
Federoff HJ, Gostin LO. Evolving from reductionism to holism: is there a future for systems medicine? JAMA. 2009;302(9):994–6.
Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35(1):2–16.
Westerhoff HV, Palsson BO. The evolution of molecular biology into systems biology. Nat Biotechnol. 2004;22(10):1249–52.
Martin CM, Peterson C. The social construction of chronicity - a key to understanding chronic care transformations. J Eval Clin Pract. 2009;15(3):578–85.
Armstrong D. The emancipation of biographical medicine. Soc Sci Med. 1979;13:1–8.
Engel GL. The biopsychosocial model and the education of health professionals. Gen Hosp Psychiatry. 1979;1(2):156–65.
Yancik R, Ershler W, Satariano W, Hazzard W, Cohen HJ, Ferrucci L. Report of the National Institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci. 2007;62(3): 275–80.
Sturmberg JP, Martin CM. Diagnosis - the limiting focus of taxonomy. J Eval Clin Pract. 2015. http://dx.doi.org/10.1111/jep.12113. Accessed 21 Dec 2015 [online version 2014].
van der Heijden MJ, Schroen Y. Global advances in health and medicine through systems biology: an example from the Netherlands. Global Adv Health Med. 2012;1(4):92–3.
Strauss VY, Jones PW, Kadam UT, Jordan KP. Distinct trajectories of multimorbidity in primary care were identified using latent class growth analysis. J Clin Epidemiol. 2014;67(10):1163–71.
Baylis D, Bartlett DB, Syddall HE, Ntani G, Gale CR, Cooper C, et al. Immune-endocrine biomarkers as predictors of frailty and mortality: a 10-year longitudinal study in community-dwelling older people. Age (Dordr.) 2013;35(3):963–71.
Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am. Heart J 2009;158(4):659–66.
Peters S, Janssen H-G, Vivő-Truyols G. Trend analysis of time-series data: a novel method for untargeted metabolite discovery. Anal Chim Acta. 2010;663(1):98–104.
Cole SW. Social regulation of human gene expression: mechanisms and implications for public health. Am J Public Health. 2013;103 Suppl 1:S84–92.
Christian LM, Glaser R, Porter K, Malarkey WB, Beversdorf D, Kiecolt-Glaser JK. Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology. 2011;36(10):1495–1504.
Jylhä M, Volpato S, Guralnik J. Self-rated health showed a graded association with frequently used biomarkers in a large population sample. J Clin Epidemiol. 2006;59:465–71.
Juster RP, Marin MF, Sindi S, Nair NP, Ng YK, Pruessner JC, Lupien SJ. Allostatic load associations to acute, 3-year and 6-year prospective depressive symptoms in healthy older adults. Physiol Cehavior. 2011;104(2):360–64.
Picard M, Juster R, Sabiston C. Is the whole greater than the sum of the parts? Self-rated health and transdisciplinarity. Health. 2013;5:24–30.
Salanitro AH, Ritchie CS, Hovater M, Roth DL, Sawyer P, Locher JL, et al. Inflammatory biomarkers as predictors of hospitalization and death in community-dwelling older adults. Arch Gerontol Geriatr. 2012;54(3):e387–91.
Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op’t Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–35.
Melis R, Marengoni A, Angleman S, Fratiglioni L. Incidence and predictors of multimorbidity in the elderly: a population-based longitudinal study. PloS One. 2014;9(7):e103120.
Kurtz C, Snowden D. The new dynamics of strategy: Sense-making in a complex and complicated world. IBM Syst J. 2003;42(3):462–83.
Morgan WK. Letter: Medical-industrial complex. Lancet. 1974;1(7847):96.
Relman AS. The new medical-industrial complex. N Engl J Med. 1980;303(17):963–70.
Halfon N, Larson K, Lu M, Tullis E, Russ S. Lifecourse health development: past, present and future. Matern Child Health J. 2014;18(2):344–65.
Martin CM, Vogel C, Grady D, Zarabzadeh A, Hederman L, Kellett J, et al. Implementation of complex adaptive chronic care: the Patient Journey Record system (PaJR). J Eval Clin Pract. 2012;18(6):1226–34.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Martin, C.M. (2016). Multimorbidity: Through a Glass Darkly. In: Sturmberg, J. (eds) The Value of Systems and Complexity Sciences for Healthcare. Springer, Cham. https://doi.org/10.1007/978-3-319-26221-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-26221-5_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26219-2
Online ISBN: 978-3-319-26221-5
eBook Packages: MedicineMedicine (R0)